Massachusetts Financial Services
HRMY icon

Massachusetts Financial Services’s Harmony Biosciences HRMY Stock Holding History

Massachusetts Financial Services’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2M Buy
278,845
+8,832
+3% +$279K ﹤0.01% 759
2026
Q1 		$7.56M Sell
270,013
-271,268
-50% -$8.89M ﹤0.01% 740
2025
Q4 		$20.3M Sell
541,281
-29,258
-5% -$962K 0.01% 643
2025
Q3 		$15.7M Sell
570,539
-73,991
-11% -$2.55M ﹤0.01% 659
2025
Q2 		$20.4M Sell
644,530
-109,017
-14% -$3.51M 0.01% 614
2025
Q1 		$25M Sell
753,547
-76,073
-9% -$2.73M 0.01% 571
2024
Q4 		$28.5M Buy
829,620
+169,229
+26% +$5.81M 0.01% 552
2024
Q3 		$26.4M Buy
660,391
+140,690
+27% +$4.94M 0.01% 560
2024
Q2 		$15.7M Buy
519,701
+13,547
+3% +$407K ﹤0.01% 600
2024
Q1 		$17M Sell
506,154
-2,478
-0.5% -$79.5K 0.01% 595
2023
Q4 		$16.4M Buy
508,632
+434
+0.1% +$12.1K 0.01% 589
2023
Q3 		$16.7M Buy
508,198
+864
+0.2% +$30K 0.01% 583
2023
Q2 		$17.9M Buy
507,334
+96,397
+23% +$3.33M 0.01% 570
2023
Q1 		$13.4M Buy
410,937
+70,834
+21% +$3.23M ﹤0.01% 591
2022
Q4 		$18.7M Sell
340,103
-75,348
-18% -$4.14M 0.01% 556
2022
Q3 		$18.4M Buy
415,451
+28,539
+7% +$1.39M 0.01% 561
2022
Q2 		$18.9M Sell
386,912
-2,848
-0.7% -$128K 0.01% 563
2022
Q1 		$19M Sell
389,760
-170,108
-30% -$6.94M 0.01% 587
2021
Q4 		$23.9M Sell
559,868
-107,916
-16% -$4.3M 0.01% 590
2021
Q3 		$25.6M Sell
667,784
-8,836
-1% -$285K 0.01% 588
2021
Q2 		$19.1M Buy
676,620
+71,755
+12% +$2.15M 0.01% 620
2021
Q1 		$20M Buy
604,865
+91,295
+18% +$3.2M 0.01% 604
2020
Q4 		$18.6M Buy
513,570
+183,902
+56% +$7.42M 0.01% 599
2020
Q3 		$11.2M Buy
+329,668
New +$12M ﹤0.01% 624

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services's HRMY Position: Q2 2026 in Review

Massachusetts Financial Services increased its Harmony Biosciences (HRMY) stake by 3.3% in Q2 2026, buying an estimated $279K and bringing the position to 278,845 shares worth $10.2M. The position accounts for ﹤0.01% of the portfolio, ranked #759.

Massachusetts Financial Services first reported a position in HRMY in Q3 2020 and has held it in 24 quarters since. The position peaked at $28.5M in Q4 2024. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Massachusetts Financial Services held 278,845 shares of Harmony Biosciences worth $10.2M as of Q2 2026.
  • Massachusetts Financial Services bought 8,832 Harmony Biosciences shares in Q2 2026, an estimated $279K.
  • Harmony Biosciences made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #759 holding.
  • Massachusetts Financial Services first reported a position in Harmony Biosciences in Q3 2020 and has held it in 24 quarters since.
  • Massachusetts Financial Services's Harmony Biosciences position peaked at $28.5M in Q4 2024.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.